Global Information
회사소개 | 문의 | 비교리스트

신종 코로나바이러스 감염증(COVID-19) 진단 : 세계 시장 전망(2018-2027년)

COVID-19 Diagnostics - Global Market Outlook (2018-2027)

리서치사 Stratistics Market Research Consulting
발행일 2020년 05월 상품 코드 939154
페이지 정보 영문 140 Pages
가격
US $ 4,150 ₩ 4,728,000 PDF by E-mail (Single User License)
US $ 5,250 ₩ 5,981,000 PDF by E-mail (2-5 User License)
US $ 6,350 ₩ 7,235,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 8,545,000 PDF by E-mail (Global Site License)


신종 코로나바이러스 감염증(COVID-19) 진단 : 세계 시장 전망(2018-2027년) COVID-19 Diagnostics - Global Market Outlook (2018-2027)
발행일 : 2020년 05월 페이지 정보 : 영문 140 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 신종 코로나바이러스 감염증(COVID-19) 진단 시장은 예측 기간 중 7.6%의 CAGR로 추이하며, 2018년의 161억 3000만 달러에서 2027년에는 311억 8000만 달러 규모로 성장할 것으로 예측됩니다. 세계의 감염자 수 증가, 정확한 검사 결과의 필요성이 이 시장의 성장을 촉진하고 있습니다. 그러나 코로나바이러스와 증상, 감염력에 관한 지식의 결여가 시장의 성장을 억제하고 있습니다.

세계의 신종 코로나바이러스 감염증(COVID-19) 진단 시장을 조사했으며, 시장 및 제품의 개요, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 사용자 수·검사 유형·최종사용자·지역/주요 국가 등 각종 부문별 동향과 시장 규모의 추이와 예측, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 개요

제2장 서문

제3장 시장 동향 분석

  • 서론
  • 촉진요인
  • 억제요인
  • 시장 기회
  • 위협
  • 최종사용자 분석
  • 신흥 시장
  • Covid-19의 영향

제4장 Porter의 산업 분석

제5장 세계의 COVID-19 진단 시장 : 사용자 수별

  • 서론
  • 복수
  • 단수

제6장 세계의 COVID-19 진단 시장 : 검사 유형별

  • 서론
  • 혈청 검사
  • 분자학적 검사

제7장 세계의 COVID-19 진단 시장 : 최종사용자별

  • 서론
  • 공중위생 연구소
  • 민간·상업 랩
  • 의사 랩
  • 병원

제8장 세계의 COVID-19 진단 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카

제9장 주요 개발

  • 계약·제휴·협업·JV
  • M&A
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제10장 기업 개요

  • Alveo Technologies
  • Accelerate Diagnostics
  • Abbott Diagnostics
  • Aus Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Applied BioCode
  • BD Diagnostics
  • Cue Health
  • Biocartis
  • Co-Diagnostics
  • BioFire Diagnostics
  • Cepheid
  • bioMerieux
  • Bosch Healthcare Solutions GmbH
  • Bio-Rad Laboratories
  • Curetis
  • GenePOC Diagnostics
  • Diagenode Diagnostics
  • GenMark Dx
KSA 20.06.12

List of Tables

  • Table 1 Global COVID-19 Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 3 Global COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 4 Global COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 5 Global COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 6 Global COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 7 Global COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 8 Global COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 9 Global COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 10 Global COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 11 Global COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 12 Global COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 13 North America COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 14 North America COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 15 North America COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 16 North America COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 17 North America COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 18 North America COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 19 North America COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 20 North America COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 21 North America COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 22 North America COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 23 North America COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 24 North America COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 25 Europe COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 26 Europe COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 27 Europe COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 28 Europe COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 29 Europe COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 30 Europe COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 31 Europe COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 32 Europe COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 33 Europe COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 34 Europe COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 35 Europe COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 36 Europe COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 37 Asia Pacific COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 38 Asia Pacific COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 39 Asia Pacific COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 40 Asia Pacific COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 41 Asia Pacific COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 42 Asia Pacific COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 43 Asia Pacific COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 44 Asia Pacific COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 45 Asia Pacific COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 46 Asia Pacific COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 47 Asia Pacific COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 48 Asia Pacific COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 49 South America COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 50 South America COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 51 South America COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 52 South America COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 53 South America COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 54 South America COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 55 South America COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 56 South America COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 57 South America COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 58 South America COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 59 South America COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 60 South America COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 61 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Country (2017-2027) ($MN)
  • Table 62 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Quantity of User (2017-2027) ($MN)
  • Table 63 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Multiple (2017-2027) ($MN)
  • Table 64 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Single (2017-2027) ($MN)
  • Table 65 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 66 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Serology (2017-2027) ($MN)
  • Table 67 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Molecular (2017-2027) ($MN)
  • Table 68 Middle East & Africa COVID-19 Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 69 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Public Health Labs (2017-2027) ($MN)
  • Table 70 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Private or Commercial Labs (2017-2027) ($MN)
  • Table 71 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Physician Labs (2017-2027) ($MN)
  • Table 72 Middle East & Africa COVID-19 Diagnostics Market Outlook, By Hospitals (2017-2027) ($MN)

According to Stratistics MRC, the Global COVID-19 Diagnostics Market is accounted for $16.13 billion in 2018 and is expected to reach $31.18 billion by 2027 growing at a CAGR of 7.6% during the forecast period. Rise in number of cases of COVID-19 patients across the globe and requirement to ensure accurate test results are the major factors driving the market growth. However, lack of knowledge about corona virus, its symptoms, and its ability to spread is restraining the market growth.

COVID-19 is an infectious disease caused due to Corona virus. Its symptoms include mild to moderate respiratory discomfort. While most may recover without any need for special treatment, the virus can cause major issues or serious illness and even death in older individuals and persons with underlying medical problems such as diabetes and cancers. As it have been the cause of numerous deaths, and infections in the past there is a urgent need for accurate diagnostic methods.

Based on test type, the molecular segment is likely to have a huge demand as it involves the extraction of viral RNA from a patient's sample and synthesis of the complementary DNA (cDNA) followed by amplification of the viral genome. By geography, North America is going to have a lucrative growth during the forecast period due to the well-established healthcare system and several pharmaceutical companies.

Some of the key players profiled in the COVID-19 Diagnostics Market include Alveo Technologies, Accelerate Diagnostics, Abbott Diagnostics, Aus Diagnostics, Ador Diagnostics, Akkoni Biosystems , Applied BioCode, BD Diagnostics, Cue Health, Biocartis, Co-Diagnostics , BioFire Diagnostics, Cepheid, bioMerieux, Bosch Healthcare Solutions GmbH, Bio-Rad Laboratories , Curetis, GenePOC Diagnostics , Diagenode Diagnostics and GenMark Dx.

Quantity of Users Covered:

  • Multiple
  • Single

Test Types Covered:

  • Serology
  • Molecular

End Users Covered:

  • Public Health Labs
  • Private or Commercial Labs
  • Physician Labs
  • Hospitals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global COVID-19 Diagnostics Market, By Quantity of User

  • 5.1 Introduction
  • 5.2 Multiple
  • 5.3 Single

6 Global COVID-19 Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Serology
  • 6.3 Molecular

7 Global COVID-19 Diagnostics Market, By End User

  • 7.1 Introduction
  • 7.2 Public Health Labs
  • 7.3 Private or Commercial Labs
  • 7.4 Physician Labs
  • 7.5 Hospitals

8 Global COVID-19 Diagnostics Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Alveo Technologies
  • 10.2 Accelerate Diagnostics
  • 10.3 Abbott Diagnostics
  • 10.4 Aus Diagnostics
  • 10.5 Ador Diagnostics
  • 10.6 Akkoni Biosystems
  • 10.7 Applied BioCode
  • 10.8 BD Diagnostics
  • 10.9 Cue Health
  • 10.10 Biocartis
  • 10.11 Co-Diagnostics
  • 10.12 BioFire Diagnostics
  • 10.13 Cepheid
  • 10.14 bioMerieux
  • 10.15 Bosch Healthcare Solutions GmbH
  • 10.16 Bio-Rad Laboratories
  • 10.17 Curetis
  • 10.18 GenePOC Diagnostics
  • 10.19 Diagenode Diagnostics
  • 10.20 GenMark Dx
Back to Top
전화 문의
F A Q